CompletedPhase 4NCT06534671
Diltiazem in Jervell and Lange-Nielsen Syndrome
Studying Jervell and Lange-Nielsen syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Prince J Kannankeril, MD, MSCI, MDVanderbilt University Medical Center
- Intervention
- diltiazem(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2024
Study locations (1)
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06534671 on ClinicalTrials.gov